Gloria A Ansa1, John D Walley2, Kamran Siddiqi2, Xiaolin Wei2. 1. Nuffield Centre for International Health and Development, University of Leeds, 101 Clarendon Road, Leeds LS2 9LJ, UK nana_akosua@yahoo.com. 2. Nuffield Centre for International Health and Development, University of Leeds, 101 Clarendon Road, Leeds LS2 9LJ, UK.
Abstract
BACKGROUND: TB and HIV interaction increases TB incidence and HIV adverse outcomes. Integration improves patients' access to comprehensive care. This paper compares the impact of increasing integration on TB/HIV service delivery. METHODS: Three hospitals with different delivery models were identified and a survey of TB cases registered between June 2007 and December 2008 conducted. HIV screening, co-trimoxazole preventive therapy (CPT) and antiretroviral therapy (ART) uptake for HIV-positive TB patients were compared. RESULTS: Of the 590 TB patients, 85.9% (507/590) knew their HIV status. HIV screening was highest (98.6% [95%CI: 97.6-99.5%]) at the one-stop shop (OSS) and lowest (72.5% [71.9-73.9%]) at the referral site (RS). CPT was highest [(93.8% [91.0-96.7%]) at the RS and least (74.7% [72.8-76.5%]) at the partially-integrated site (PIS). At the OSS it was 82.3% (80.6-84.0%). ART was highest (59.5% [58.0-61.0%]) at the PIS, and 10.8% (10.4-11.1%) at the RS. No ART records existed at the OSS. CONCLUSIONS: Increasing integration improved HIV screening but not CPT or ART uptake. There was insufficient evidence to identify the most effective model due to design limitations and health system barriers. More research and training is needed to improve uptake, data completeness and accuracy.
BACKGROUND: TB and HIV interaction increases TB incidence and HIV adverse outcomes. Integration improves patients' access to comprehensive care. This paper compares the impact of increasing integration on TB/HIV service delivery. METHODS: Three hospitals with different delivery models were identified and a survey of TB cases registered between June 2007 and December 2008 conducted. HIV screening, co-trimoxazole preventive therapy (CPT) and antiretroviral therapy (ART) uptake for HIV-positive TB patients were compared. RESULTS: Of the 590 TB patients, 85.9% (507/590) knew their HIV status. HIV screening was highest (98.6% [95%CI: 97.6-99.5%]) at the one-stop shop (OSS) and lowest (72.5% [71.9-73.9%]) at the referral site (RS). CPT was highest [(93.8% [91.0-96.7%]) at the RS and least (74.7% [72.8-76.5%]) at the partially-integrated site (PIS). At the OSS it was 82.3% (80.6-84.0%). ART was highest (59.5% [58.0-61.0%]) at the PIS, and 10.8% (10.4-11.1%) at the RS. No ART records existed at the OSS. CONCLUSIONS: Increasing integration improved HIV screening but not CPT or ART uptake. There was insufficient evidence to identify the most effective model due to design limitations and health system barriers. More research and training is needed to improve uptake, data completeness and accuracy.
Authors: Ivy Mannoh; Danielle Amundsen; Gnilane Turpin; Carrie E Lyons; Nikita Viswasam; Elizabeth Hahn; Sofia Ryan; Stefan Baral; Bhakti Hansoti Journal: AIDS Behav Date: 2021-11-19
Authors: Susanne Mueller-Using; Torsten Feldt; Fred Stephen Sarfo; Kirsten Alexandra Eberhardt Journal: BMC Public Health Date: 2016-07-13 Impact factor: 3.295
Authors: Giorgia Sulis; Rosella Centis; Giovanni Sotgiu; Lia D'Ambrosio; Emanuele Pontali; Antonio Spanevello; Alberto Matteelli; Alimuddin Zumla; Giovanni Battista Migliori Journal: NPJ Prim Care Respir Med Date: 2016-11-03 Impact factor: 2.871
Authors: Beth Rachlis; Giorgos Bakoyannis; Philippa Easterbrook; Becky Genberg; Ronald Scott Braithwaite; Craig R Cohen; Elizabeth A Bukusi; Andrew Kambugu; Mwebesa Bosco Bwana; Geoffrey R Somi; Elvin H Geng; Beverly Musick; Constantin T Yiannoutsos; Kara Wools-Kaloustian; Paula Braitstein Journal: PLoS One Date: 2016-08-10 Impact factor: 3.240
Authors: Juan Ignacio García; Johanna Meléndez; Rosa Álvarez; Carlos Mejía-Chew; Holden V Kelley; Sabeen Sidiki; Alejandra Castillo; Claudia Mazariegos; Cesar López-Téllez; Diana Forno; Nancy Ayala; Joan-Miquel Balada-Llasat; Carlos Rodolfo Mejía-Villatoro; Shu-Hua Wang; Jordi B Torrelles; Janet Ikeda Journal: AIDS Res Ther Date: 2020-10-19 Impact factor: 2.846